Let me preface my comments by saying I am not a "finance guy", and the calculations below are my own...
GSK has said that they will return 4b pounds to investors.
Based on what I see on yahoo now...GSK (ADR) market cap of 112.8b and a share price of just under $47 a share, there are (approx) 2.4b shares.
If you convert the 4b pounds to $ (approx 1.5 $ per pound), they should pay out approx $6b.
$6b divided by 2.4b shares is $2.50 per share.
Philip Hampton, the new COB, will step into that role after the Annual Meeting on May 7. We'll see what happens once he is "on board".
I don't think the "dividend paid date" is a big date for making announcements. They are scheduled to announce the "July dividend" on May 6. I am hoping for an announcement as soon as possible, but I see May 6 as a target for the announcement. JMHO
I'm not sure I understand. If you thought the company could fetch a deal in the 50s in 2017, why in the world would you accept a deal in the 20s this year???
I think the company has acknowledged that a fast casual concept is in the works. The first stores are expected to be open by the end of the next fiscal year (ie - July 2016).
Yes. I guess I should have qualified by statements. They were in reference to regular dividends only.
I haven't seen any updates to the comments from last April that they intend to return 4 billion pounds to shareholders after completion of the Novartis deals. I wish I understood better how the B share scheme works. I assume we will hear more from the company soon.
If you look at it Q to Q, the April dividend does look like an increase. The right way to look at GSK's dividend is Y to Y, based on how they pay it.
The last 2 quarterly dividends of 2014 (those paid in Jan, 2015 and April, 2015) both reflect no increase from the previous year.
When GSK announced their 3rd quarter results in October, they stated that their aim was to maintain the 3rd and 4th quarter dividends (ie - no increase), as well as to maintain the 2015 dividend at the 2014 level. This suggests that the next 4 quarterly dividends (to be paid in July, Oct, Jan16 and April16) will be 19p, 19p, 19p and 23p per share. Due to currency fluctuations, the dividends in $ will vary a bit. While there is never a guarantee, I would bet that this level of dividend payout is safe. Even without increases, this reflects a hefty dividend, compared to the market.
OK, Biglari owns 20%, and gets a dividend that reflects that number of shares. Can you explain to me why I should care? Would it make a difference if Vanguard, or Blackrock, or Neuberger Berman owned 20% instead?
wadr, the fact that you remember that she bought them for you suggests that you did LISTEN to her. The real lesson is when we start to actually ACT on what we hear from them!!!
Don't interpret this comment the wrong way - I am long GSK and plan on holding for quite a while. But, investors should be aware of how GSK pays its dividends...see my comment to the "Is dividend sustainable ?" topic from Feb 10. Based on how GSK pays its dividends, the 6% that Yahoo reports on the GSK summary page is not accurate. Also, investors should NOT expect GSK to match the April dividend in the following 3 quarters. While lower payouts may naively look like dividend decreases, in fact, they will not be.